Stocks & Investing
Stocks and Investing
Stocks and Investing
Mon, February 13, 2023
[ Mon, Feb 13th 2023
] - WOPRAI
[ Mon, Feb 13th 2023
] - WOPRAI
[ Mon, Feb 13th 2023
] - WOPRAI
[ Mon, Feb 13th 2023
] - WOPRAI
[ Mon, Feb 13th 2023
] - WOPRAI
[ Mon, Feb 13th 2023
] - WOPRAI
[ Mon, Feb 13th 2023
] - WOPRAI
[ Mon, Feb 13th 2023
] - WOPRAI
[ Mon, Feb 13th 2023
] - WOPRAI
[ Mon, Feb 13th 2023
] - WOPRAI
[ Mon, Feb 13th 2023
] - WOPRAI
[ Mon, Feb 13th 2023
] - WOPRAI
[ Mon, Feb 13th 2023
] - WOPRAI
[ Mon, Feb 13th 2023
] - WOPRAI
[ Mon, Feb 13th 2023
] - WOPRAI
[ Mon, Feb 13th 2023
] - WOPRAI
[ Mon, Feb 13th 2023
] - WOPRAI
[ Mon, Feb 13th 2023
] - WOPRAI
[ Mon, Feb 13th 2023
] - WOPRAI
[ Mon, Feb 13th 2023
] - WOPRAI
[ Mon, Feb 13th 2023
] - WOPRAI
[ Mon, Feb 13th 2023
] - WOPRAI
[ Mon, Feb 13th 2023
] - WOPRAI
[ Mon, Feb 13th 2023
] - WOPRAI
[ Mon, Feb 13th 2023
] - WOPRAI
[ Mon, Feb 13th 2023
] - WOPRAI
[ Mon, Feb 13th 2023
] - WOPRAI
[ Mon, Feb 13th 2023
] - WOPRAI
[ Mon, Feb 13th 2023
] - WOPRAI
[ Mon, Feb 13th 2023
] - WOPRAI
Gregory Renza Maintained (SPRB) at Buy with Decreased Target to $8 on, Feb 13th, 2023
Gregory Renza of RBC Capital, Maintained "Spruce Biosciences, Inc." (SPRB) at Buy with Decreased Target from $9 to $8 on, Feb 13th, 2023.
Gregory has made no other calls on SPRB in the last 4 months.
There are 2 other peers that have a rating on SPRB. Out of the 2 peers that are also analyzing SPRB, 0 agree with Gregory's Rating of Hold.
These are the ratings of the 2 analyists that currently disagree with Gregory
- Jonathan Wolleben of "JMP Securities" Maintained at Buy and Held Target at $8 on, Sunday, January 8th, 2023
- Hartaj Singh of "Oppenheimer" Maintained at Buy with Decreased Target to $8 on, Thursday, November 17th, 2022
